🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 576810105
- Market Cap
- Small Cap
Business: Matinas Biopharma Holdings, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative anti-infectives for orphan indications. The Company's proprietary, disruptive technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, making them safer, more tolerable, less toxic and orally bioavailable.
Company Contact
- CEO
- Jerome D. Jabbour
- CFO
- Keith A. Kucinski
- Headquarters
- 1545 Route 206 South, Suite 302, Bedminster, NJ 07921
- Phone
- 908-484-8805
- Investor Relations
- Ian Cooney · 415-722-4563 · icooney@matinasbiopharma.com